Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM

6.58 Up 1.08(19.64%) May 17, 4:00PM EDT|After Hours : 6.58 0.00 (0.00%) May 17, 4:32PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 8,068   7,920   8,288   8,378  
Cost of Revenue -  129   -   -  
Gross Profit 8,068   7,791   8,288   8,378  
Operating Expenses
Research Development7,960  10,617  10,159  12,490  
Selling General and Administrative3,958  3,225  3,147  3,601  
Non Recurring -   -   -   -  
Others369  377  377  372  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (4,219) (6,428) (5,395) (8,085)
Income from Continuing Operations
Total Other Income/Expenses Net46  59  69  78  
Earnings Before Interest And Taxes(4,173)(6,369)(5,326)(8,007)
Interest Expense -   -   -   -  
Income Before Tax(4,173)(6,369)(5,326)(8,007)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(4,173)(6,369)(5,326)(8,007)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (4,173) (6,369) (5,326) (8,007)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (4,173) (6,369) (5,326) (8,007)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.